The Impact of Pediatric Labeling Changes on Prescribing Patterns of Cough and Cold Medications

摘要

Objective To evaluate the impact of initiatives created by the pharmaceutical industry and the Food and Drug Administration to limit the use of over-the-counter (OTC) cough and cold medications (CCMs) in young children in emergency departments (EDs) and ambulatory clinics.